Mireille Adda

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia

Olivier Hermine, Xavier Mariette, Pierre‐Louis Tharaux et al. · JAMA Internal Medicine · 2020 · 777 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +14

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

Pierre‐Louis Tharaux, Gilles Pialoux, Arthur Pavot et al. · The Lancet Respiratory Medicine · 2021 · 296 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +14

High-Dose Dexamethasone and Oxygen Support Strategies in Intensive Care Unit Patients With Severe COVID-19 Acute Hypoxemic Respiratory Failure

Lila Bouadma, Armand Mekontso Dessap, Charles Burdet et al. · JAMA Internal Medicine · 2022 · 148 citations · Full text

Medicine, Pharmacotherapy, Critical Care Pharmacotherapy +16

Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation

Benjamin Bonnet, Justine Cosme, Claire Dupuis et al. · EBioMedicine · 2021 · 68 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial

Ron Wald, Stèphane Gaudry, Bruno R. da Costa et al. · Intensive Care Medicine · 2023 · 61 citations · Full text

Medicine, Nephrology, Critical Care Medicine +12